Objective: Dyspareunia is a common sexual dysfunction. There is a lack of studies that address female sexual dysfunction in Puerto Rico. The present cross-sectional study characterized dyspareunia in a sample of Puerto Rican women aged 40 to 59 years and evaluated the relationship between reported dyspareunia with demographic, lifestyle, and health factors.
F emale sexual dysfunction is a multicausal and multidimensional problem that combines sexual, physiological, physical, psychological, and interpersonal determinants, having a major impact on interpersonal relationships and quality of life. 1, 2 Data from the National Health and Social Life Survey found that sexual dysfunction is highly prevalent in women (43%). 2<4 Community-based studies indicate a prevalence of sexual dysfunction among all women between 25% and 63%, 2, 3, 5 whereas the prevalence of sexual dysfunction in postmenopausal women varies from 68% to 87%. 3, 6 Among the sexual dysfunctions described in women, dyspareunia seems to be common, with a prevalence of 7% in a national probability sample assessing sexual dysfunction in the United States. 2 In a more recent meta-analysis of subtypes of chronic pelvic pain sponsored by the World Health Organization, the prevalence of dyspareunia varied from 1% in Sweden to 45% in the United States and ranged from 8% to 21% when high-quality studies with representative samples were analyzed. 7, 8 Dyspareunia is defined by the American College of Obstetricians and Gynecologists 9 as genital pain experienced just before, during, or after sexual intercourse. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV ) describes dyspareunia as recurrent or persistent vaginal pain associated with sexual intercourse in either a male or a female. 10 Historically, dyspareunia has been classified as a sexual disorder involving pain. 1, 10 Other studies classify dyspareunia as a pain syndrome resulting in sexual dysfunction. 11<14 Dyspareunia can be subdivided into two groups, superficial/entry/introital dyspareunia and deep dyspareunia, with different etiologies and treatment options. 8, 11, 15 The Report of the International Consensus Development Conference on Female Sexual Dysfunction evaluated and revised existing definitions and classifications of female sexual dysfunction. As part of this revision, a new category of noncoital sexual pain was added, which recognizes that sexual activity for women does not necessarily involve penile vaginal intercourse and may apply to nonheterosexual women engaging in alternative sexual behaviors. 1 Sexual pain is also characterized by vulvodynia, classified as any type of vulvar pain, and vulvar vestibulitis syndrome (VVS), a subcategory of vulvodynia and a diagnosis of exclusion. 15 VVS is defined as severe pain with vestibular touch or attempted vaginal entry, tenderness to cotton swab pressure localized to the vulvar vestibule, and physical findings confined to various degrees of vestibular erythema. 8 Vaginismus, classified in the DSM-IV as a sexual pain disorder, is defined as recurrent or persistent involuntary contraction of the perineal muscles surrounding the outer third of the vagina when vaginal penetration with penis, finger, tampon, or speculum is attempted. 10 There is marked overlap in the definitions of dyspareunia, VVS, and vaginismus, making the diagnosis and treatment of these conditions a challenge for clinicians.
A number of factors have been consistently described in the literature to be associated with dyspareunia, including lower educational attainment, interpersonal relationships, depressive symptoms, menopause, low sexual desire, and pelvic floor disorders. 2,8,11,13,15<24 In addition, differences in ethnicity and cultural beliefs have been shown to influence the occurrence and reporting of sexual dysfunction. 2, 25 Laumann et al 2 reported lower rates of sexual problems in Hispanic women in the United States than in whites and blacks. Nonetheless, recent studies conducted in Hispanic populations in their native countries have reported high rates of female sexual dysfunction. 25, 26 There is a lack of studies that address female sexual dysfunction in Puerto Rican women living in Puerto Rico. To our knowledge, this is the first study conducted in this population that intends to describe health and lifestyle factors associated with dyspareunia. The present crosssectional study characterized dyspareunia, defined as pain or discomfort when having sexual relations, in a sample of middle-aged (40-59 y) Puerto Rican women, and evaluated the relationship between reported dyspareunia and demographic, lifestyle, and health factors.
METHODS

Study participants and data collection
Between May 2000 and November 2001, the Centro Mujer y Salud of the School of Medicine of the University of Puerto Rico hosted 73 health fairs in 22 municipalities across Puerto Rico. The data collection instrument, a self-administered history questionnaire, obtained information on demographic characteristics, lifestyle practices, and obstetric and gynecologic history, including menstrual status, the use of oral contraceptives (OC), hormonal therapy (HT) use, symptom experience, and sexual problems. Additional details about the study design and data collection have been previously described elsewhere. 27, 28 A total of 3,258 women attended these fairs, although 777 did not fill out the questionnaire. Seventy women did not sign the informed consent, 711 women were outside the eligible age group of 40 to 59 years, and 39 were not from a Puerto Rican ethnic background. Among the 1,661 eligible women, 350 did not provide responses to demographic and reproductive sections of the questionnaire, 39 did not identify cessation of menses or provide sufficient information to determine current status of HT use, and 352 women did not provide information about symptom experience, including dyspareunia. Thus, among age-eligible study participants, 920 (55%) women were eligible for this analysis. This study was approved by the institutional review board from the University of Puerto Rico, Medical Sciences Campus.
Measurement of study variables
Dyspareunia was defined as pain or discomfort when having sexual relations experienced during the 2 months previous to answering the questionnaire. Demographic variables included the following: age, defined as a categorical variable (40-49 and 50-59 y); educational level attained, categorized into two levels (ehigh-school/technical course and Qassociate degree); current employment status (employed/unemployed); and relationship status (partner [married/living together] or no partner [single, widowed, divorced, separated]). Lifestyle characteristics considered included the following: current cigarette smoking (yes/no), physical activity defined as exercising at least twice a week, for at least 20 minutes (yes/no), and any alcohol consumption (yes/no). The health factors considered were: body mass index, obstetric and gynecologic history, and genitourinary and sexual symptoms. Body mass index was determined using self-reported height and weight and classified into three categories [G25 kg/m 2 (underweight/ normal], 25-29.9 kg/m 2 (overweight), and Q30 kg/m 2 [obese]). Obstetric history included parity measured as number of live births and categorized as 0, 1-2, and Q3 children. Gynecologic history included menopause status and use of HT and was defined as follows: premenopausal, postmenopausal without current use of HT, and postmenopausal with current use of HT. Women were defined to be premenopausal if their menses had occurred within the last 12 months previous to the interview. Postmenopause was defined as natural menopause, menses stopping for at least 12 months without surgery, pregnancy, or other obvious cause, and also defined as surgical menopause, menses stopping as a result of hysterectomy and/or bilateral oophorectomy. Lifetime use of OC was also gathered (never/ever). Genitourinary and sexual symptoms were described by vaginal itching (yes/no), vaginal dryness (yes/no), incontinence (yes/ no), and loss of libido (yes/no).
Statistical analysis
Bivariate analyses were performed using contingency tables to assess the relationship between dyspareunia and the following variables: demographic, lifestyle, and health factors. Chi-square tests were used in each contingency table to explore how individual factors were associated with dyspareunia. 29 To determine the magnitude of the association between dyspareunia and demographic, lifestyle, and health factors, the prevalence odds ratios (POR's) (crude and adjusted) were estimated with 95% CI using logistic regression models. 30 Those variables associated (P G 0.05) in bivariate analysis to dyspareunia were included in the multivariate regression model; in addition, we adjusted for the potential confounding effects of age. Interaction terms in the multivariate logistic regression model were analyzed using the likelihood ratio test. 30 No interaction was found (W 2 = 29.13, P = 0.61). Data were analyzed using SAS version 8 (SAS Institute Inc, Cary, NC).
RESULTS
Of the 920 women in the study sample, 169 (18%) reported dyspareunia. Dyspareunia was somewhat lower among women aged 40 to 49 years (17%) than among those aged 50 to 59 years (21%), but this association did not reach statistical significance. Dyspareunia was associated to educational attainment and working status, being less reported among women with higher educational attainment (14% vs 22%) and less reported among those currently working (15% vs 22%). Meanwhile, dyspareunia was higher among women with a partner (24%) than among those without a partner (8%) ( Table 1 ). Among those categorized as having no partner, the specific prevalence of dyspareunia in each subgroup was 8% for single women, 5% among widowed women, and 9% among those separated/ divorced (data not shown). Fifty-two women were excluded from this analysis because they reported current HT use and to be menstruating; thus, menopause status could not be assessed. Among gynecologic characteristics, menopausal/HT status was associated with dyspareunia (premenopause: 14%, postmenopause using HT: 25%, postmenopause not using HT: 19%; P = 0.0037). In addition, dyspareunia was more common in women with urinary incontinence (29%), vaginal dryness (37%), and vaginal itching (34%) than in women not reporting these symptoms (16%, 8%, and 14%, respectively; P G 0.0001). No association of parity and OC use with dyspareunia was observed (P 9 0.05). In addition, none of the lifestyle characteristics studied (current cigarette smoking, body mass index, physical activity, and alcohol use) were associated with dyspareunia in bivariate analysis (P 9 0.05; Table 1 ).
Multivariate analysis
In the multivariate analysis, incontinence (POR, 1.67; 95% CI, 1.02-2.73), vaginal dryness (POR, 3.97; 95% CI, 2.49-6.31), vaginal itching (POR, 2.44; 95% CI, 1.55-3.83), and loss of libido (POR, 3.08; 95% CI, 1.92-4.94) were associated to dyspareunia. In addition, women who reported having a partner were 2.22 times more likely than those without a partner to report dyspareunia (POR, 2.22; 95% CI, 1.29-3.82). Menopause status/current HT use, educational attainment, and employment status were no longer associated to dyspareunia in the multivariate analysis ( Table 2) .
DISCUSSION
This cross-sectional study characterized the relationship of dyspareunia with lifestyle and health characteristics in a sample of middle-aged Puerto Rican women aged 40 to 59 years living in Puerto Rico. Overall, 18% of the study sample reported having experienced dyspareunia during the 2 months previous to the interview. Although we do not expect this result to be representative of the prevalence of dyspareunia in Puerto Rican women, the frequency of dyspareunia observed in our study sample falls within the range (8%-21%) recently reported by the World Health Organization in a meta-analysis of subtypes of chronic pelvic pain. 7, 8 However, the proportion of women with dyspareunia in our study sample (18%) is higher than that reported in a national probability sample assessing sexual dysfunction (7%) in the United States. 2 Differences in age groups included for analysis, other population characteristics, the time frame used to define prevalence, the method of data collection used (self-administered questionnaires or interviews), and the differences in definitions of dyspareunia and pelvic pain may account for some of these differences.
Consistent with previous studies, 31, 32 we found no association between age and dyspareunia. Nonetheless, the association between age and dyspareunia has not always been consistent. Age has also been found to be a protective factor against dyspareunia, with the prevalence of dyspareunia decreasing with increasing age. 2, 23, 24 Laumann et al 2 found that young women are more likely to be single, with a higher turnover of partners leading to instability and inexperience, thus generating stressful sexual encounters and consequently experiencing sexual pain. On the contrary, a study by Nappi et al 18 did find an association with dyspareunia and increasing age.
Meanwhile, relationship status was found to have a significant association with dyspareunia in multivariate analysis, with women with a partner having 2.3 times the possibility of having dyspareunia than those without a partner, a result not consistent with previous studies. 2, 33 This variation may be due to differences in how relationship status is defined. In our study population, only those women married or living in a consensual relationship were considered as having a partner, whereas single, divorced, and widowed women and those separated from their husbands were considered as not having a partner. Thus, it may be possible that some of the women categorized as without a partner may indeed have a stable relationship with a partner. Also, the amount of current and lifetime sexual partners might influence a woman's sexual intimacy with a partner. Thus, these and other factors affecting a couple's relationship such as the quality of the interpersonal relationship and adjustment with the partner, the partner's psychological and physical state, the couple's sexual habits, and the frequency of intercourse should be evaluated to establish if the marital relationship of Puerto Rican women is being affected by the dysfunction or the dysfunction seemed to be a consequence of the relationship.
Regarding education, our results show no association between educational attainment and dyspareunia in multivariate analysis. This is consistent with a study conducted by Jamieson and Steege. 31 However, other studies support the association that having a greater educational attainment reduces the likelihood of dyspareunia. 20, 23, 24, 32 Parity and OC pills were not found to be associated with dyspareunia in our population. Jamieson and Steege 31 reported no significant association between dyspareunia and parity, whereas Sobhgol and Charndabee 32 did find a significant association, attributing it mostly to the impairment of pelvic floor functioning during pregnancy and delivery. The mode of delivery and its complications and the use of OC pills, which has been implicated in adverse sexual response, 34 should be further evaluated in this population because these two factors could influence the prevalence of dyspareunia.
There are conflicting data as to whether the menopausal transition increases the risk of dyspareunia. In our study, menopause status/current HT use was associated to dyspareunia in the bivariate analysis, with postmenopausal women using HT (25%) reporting more dyspareunia than postmenopausal women not using HT (19%) and premenopausal women (14%). However, in multivariate regression analysis, the association was no longer present. Some studies show that dyspareunia increases throughout the menopausal transition, 16, 18, 22, 24, 33, 35 whereas others show no association. 23, 36, 37 Estradiol levels are negatively associated with dyspareunia, 36, 37 whereas estrogen therapy has been found to reduce dyspareunia. 22, 24 In the United States, the percentage of postmenopausal women using HT is approximately 38%, higher than that of our study population, which was 24%. In our study, we could not show that dyspareunia increases with postmenopause status or that HT use is associated with a decrease in dyspareunia. This could be due to the small number of postmenopausal women currently using HT; the type, dose, and route of HT used; and compliance with treatment.
Vaginal dryness and vaginal itching, common symptoms of vaginal atrophy, can also cause pain with sexual activity. 16, 36, 38 Vaginal atrophy is a consequence of urogenital aging and affects 50% of postmenopausal women. 39 It occurs as a result of a decrease in estrogen levels, and its prevalence markedly increases from early to late perimenopause and then to postmenopause. 16, 35 In our study, women with vaginal itching and women with vaginal dryness were approximately two to four times (respectively) as likely as those without these symptoms to have dyspareunia, supporting the relationship between vaginal atrophy and dyspareunia. Sexual pharmacology is the mainstay of treatment for many female sexual complaints as is the use of topical estrogen and nonmedicated, nonhormonal vaginal moisturizers and lubricants. 15, 34, 38, 39 These treatment modalities have been used to relieve symptoms of vaginal atrophy successfully, showing improvement or prevention of dyspareunia, with the possibility of establishing a causal relationship between vaginal atrophy and dyspareunia.
Loss of libido as a result of dyspareunia has been documented, 38 and dyspareunia has been associated with more sexual function impairment. 13, 15 In this study, women with loss of libido had a higher possibility of having dyspareunia than women without desire problems. Women with dyspareunia have been found to have lower levels of desire and arousal and less orgasmic response with oral stimulation and intercourse. 2, 15 Vaginal atrophy causing dyspareunia can lead to loss of interest in sex. 38 However, some studies have proposed that dyspareunia might reflect a sexual arousal problem, masked by the symptoms of vaginal atrophy, rather than a direct consequence of the symptoms. 18, 38 Further research is needed to address this issue.
Urinary tract symptoms, including urinary incontinence, have also been associated with dyspareunia in previous studies. 2, 16, 19, 20 Consistent with these studies, women in our study with incontinence were 67% more likely to have dyspareunia than those without incontinence. Thus, the severity and type of incontinence should be evaluated in this population because this could influence the prevalence of dyspareunia in our population.
Several study limitations need to be considered when interpreting our results. Our results may be affected by selection bias because only women who attended the health fairs were recruited into the study. Because one of the main focuses of the health fairs was to provide information on menopause and HT, women recruited into the study might have been those most affected by symptoms; thus, selection bias might account for the high prevalence of symptoms observed among our study sample. To assess the potential of this selection bias, previous comparisons of our study sample with data from the Puerto Rico Public Use Microdata Sample (5%) from the Census 2000 for women aged 40 to 59 years have been made. 27 Overall, our study sample was similar to the Census 2000 in the distribution of marital status, although a larger proportion of women aged 45 to 49 years (30%) and a smaller proportion of women aged 55 to 59 years (17%) were included in the study as compared with the census (26% and 21%, respectively). Study participants were also more likely to be employed (56%) than in the census (41%) and had higher educational attainment. Another source of selection bias could be the fact that 21% of eligible women (n = 352) did not answer the section of symptoms of the questionnaire. As a result, women with symptoms could have been less likely to answer this section of the survey, potentially underestimating the prevalence of dyspareunia in the study population. Nonetheless, information on dyspareunia was collected as part of a section that assessed information on 22 symptoms related to women's health. Thus, the missing information was not selective to dyspareunia, as women who did not provide information on this condition did so because they left the complete symptoms section blank. To assess the potential for this selection bias, we compared the demographic characteristics of the study population (n = 920) with that of those eligible women excluded from the analysis because they did not provide information on dyspareunia (n = 352). Results showed that these groups did not differ in educational attainment, relationship, or working status (P 9 0.05), although a higher proportion of women aged 40 to 49 years did not answer the symptoms section of the survey (36.2%) as compared to those aged 50 to 59 years (18.6%; P G 0.0001).
Our results may also be affected by information bias because the definitions of dyspareunia and other characteristics studied were based on self-reports and not based on official diagnostic definitions. According to the DSM-IV, dyspareunia is defined as recurrent or persistent genital pain associated with sexual intercourse in either a male or a female. Although the symptoms of sexual pain reported by the women in this study are mostly included in the definition of dyspareunia, the onset of symptoms, the length of time of symptom duration since its onset, the frequency of symptoms, the previous sexual functioning of study participants, and the impact of the sexual complaint on quality of life was not assessed in the questionnaire. In addition, the type of dyspareunia, superficial/ entry/introital or deep, was not described. A medical evaluation was also not performed to exclude other forms of sexual pain such as vaginismus and vulvodynia.
CONCLUSIONS
This study constitutes the first attempt to characterize health and lifestyle factors associated with dyspareunia in a middleaged sample of Puerto Rican women living in Puerto Rico. Female sexual dysfunction is a complex disorder including sexual well-being and physiological and psychosocial factors poorly studied in our population. Nonetheless, our results agreed with previous studies regarding the potential association between health and lifestyle factors and dyspareunia. Given the high complexity and the recent biopsychosocial approach given to the study of female sexual dysfunction, along with the high prevalence of self-reported dyspareunia observed in our study population, additional studies of female AVELLANET ET AL sexual dysfunction and its association with biopsychosocial factors are highly warranted, as well as studies focused on determining additional independent factors associated with other sexual symptoms and dysfunctions in Puerto Rico. These studies should recruit population-based samples of Puerto Rican women to provide unbiased estimates of the prevalence of dyspareunia and its risk factors in our population and should use appropriate diagnostic tools to correctly measure dyspareunia and reduce the potential for misclassification bias. In addition, future research should include a thorough personal history on sociodemographic matters and a psychosexual history, including history of traumatic sexual acts during childhood or adolescence, along with a complete obstetric and gynecologic history detailing reproductive matters such as mode of delivery and its complications and breastfeeding practices, surgical history, surgical sterilization and hysterectomy, and pelvic floor disorders. All of these factors were not analyzed in our study and could also be associated with sexual symptoms and dysfunctions in Puerto Rican women.
Sexual dysfunction and its implications in the quality of life of women are relevant areas of women's health, still not openly discussed by women in general, 40 that require further attention within our healthcare setting. Clinicians must consider the need to inquire and orient patients about the presence of sexual matters when at clinics to increase women's awareness of sexual health problems and to assess the effect of these problems on their quality of life. This will be essential for developing appropriate intervention strategies, including a broad-spectrum diagnosis and treatment approach that promotes and maintains the sexual health of female populations.
